SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

DIVIS LABORATORIES

BSE: 532488 29 Sep 2025
Healthcare
₹ 6041.05
Divi's Laboratories Ltd. specializes in Pharmaceuticals within the Healthcare sector.

DIVIS LABORATORIES - Share Price & Details

Market Cap
₹1,51,038
High /Low
7,078 / 4,942
Stock P/E
65.5
Book Value
₹564.0
Dividend Yield
0.53
ROCE
20.4
ROE
₹15.4
Face Value
2.0
PEG Ratio
-6.84
EVEBITDA
₹42.5
Debt
4.00
CMP / FCF
184.0
Debt to equity
₹0.0
NP Ann
2,191
High price all time
7,078
Piotroski score
₹7.0
Graham Number
1,050
No. Eq. Shares
26.6
Net CF
₹50.0
Net profit
2,306
Price to book value
10.1
Interest Coverage
₹610.0
Low price all time
45.0
Industry PE
33.0
Reserves
₹14,916
Free Cash Flow
₹215

Broker Recommendations

Date Author Type Reco Price Target Price Potential Source PDF Link
10 Sep 2025 Geojit Financial Services Sell ₹6,000.05 ₹5,400 -10.4% moneycontrol View
07 Aug 2025 Prabhudas Lilladher Buy ₹6,134.25 ₹6,550 6.8% moneycontrol View
23 May 2025 ICICI Securities Sell ₹6,451.2 ₹5,610 -14.3% moneycontrol View
23 May 2025 Deven Choksey Buy ₹6,538.3 ₹7,518 15.9% moneycontrol View
19 May 2025 ICICI Securities Sell ₹6,583.65 ₹5,610 -13.4% moneycontrol View
05 Feb 2025 KRChoksey Buy ₹6,092.2 ₹6,435 5% moneycontrol View
04 Feb 2025 Prabhudas Lilladher Buy ₹5,889.3 ₹6,250 2.5% moneycontrol View
03 Feb 2025 Motilal Oswal Hold ₹5,889.3 ₹6,200 1.2% moneycontrol View
11 Nov 2024 Sharekhan Buy ₹5,893.8 ₹6,812 9% moneycontrol View
11 Nov 2024 Prabhudas Lilladher Buy ₹5,893.8 ₹6,000 -3.9% moneycontrol View
06 Nov 2024 Prabhudas Lilladher Sell ₹5,939.7 ₹1,335 -78.6% moneycontrol View
04 Aug 2024 ICICI Securities Sell ₹4,990.35 ₹3,670 -41.2% moneycontrol View
04 Aug 2024 Prabhudas Lilladher Buy ₹4,990.35 ₹5,000 -19.4% moneycontrol View
29 Jul 2024 Prabhudas Lilladher Sell ₹4,923.25 ₹6,000 -3.3% moneycontrol View
28 May 2024 KRChoksey Hold ₹4,390.85 ₹4,478 -27.8% moneycontrol View
27 May 2024 Prabhudas Lilladher Buy ₹4,254 ₹4,350 -29.9% moneycontrol View
03 Apr 2024 KRChoksey Buy ₹3,684 ₹3,931 -36.7% moneycontrol View

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
DIVIS LABORATORIES LTD.24760.05570.023570.020.951,51,03865.5
CIPLA LTD.53172.413031.350461.716.1212111522.5
TORRENT PHARMACEUTICALS LTD.26110.05510.026160.016.2812051559.7

Peer Comparison Chart


About DIVIS LABORATORIES

Divi's Laboratories Ltd., with Security Code 532488, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

DIVISLAB Outlook for the Week

(20 Sep 2025)
Technically, Divis Laboratories share price will see immediate support at 6,022.67 and immediate resistance would be seen at 6,328.67.
Read more →

Divi’s Laboratories stock initiated at Overweight by JPMorgan on GLP-1 growth

(19 Sep 2025)
Investing.com - JPMorgan initiated coverage on Divi's Laboratories Ltd (NS:DIVI) with an Overweight rating and a price target of INR7,800,...
Read more →

Stocks To Buy: JPMorgan bets on two CRDMO plays; Check price targets

(19 Sep 2025)
Global brokerage firm JPMorgan has initiated coverage on Divi's Laboratories Ltd. and Cohance Lifesciences Ltd. with an 'Overweight' rating...
Read more →

Indian Pharma Exports Surge In August: Laurus, Divis Lead Growth

(17 Sep 2025)
Neuland Laboratories Ltd. reported exports worth $12 million in August 2025, marking a massive 433% year-on-year growth and a 250%...
Read more →

Divis Labs Share Price Live Updates: Divis Labs struggles with recent performance

(15 Sep 2025)
Stay up-to-date with the Divis Labs Stock Liveblog, your trusted source for real-time updates and thorough analysis of a prominent stock.
Read more →

Sun Pharma, Cipla, Dr Reddy’s, Zydus Lifesciences, Divi’s Labs, Torrent Pharma et al: Parsing through the pharma value chain

(14 Sep 2025)
Navigating the complexities of the pharmaceutical industry, from innovator economics to generics, CRDMO, and biosimilars for growth...
Read more →